Erum A Hartung1,2, Juan S Calle-Toro3, Carolina Maya Lopera4, Jessica Wen5,6, Robert H Carson3, Mohini Dutt7, Kathryn Howarth7, Susan L Furth7,5, Kassa Darge3,8, Suraj D Serai3,8. 1. Division of Nephrology, Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA, 19104, USA. hartunge@email.chop.edu. 2. Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. hartunge@email.chop.edu. 3. Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. 4. Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, USA. 5. Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. 6. Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA. 7. Division of Nephrology, Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA, 19104, USA. 8. Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Abstract
OBJECTIVES: To evaluate whether liver and spleen magnetic resonance elastography (MRE) can measure the severity of congenital hepatic fibrosis (CHF) and portal hypertension (pHTN) in individuals with autosomal recessive polycystic kidney disease (ARPKD), and to examine correlations between liver MRE and ultrasound (US) elastography. METHODS: Cross-sectional study of nine individuals with ARPKD and 14 healthy controls. MRE was performed to measure mean liver and spleen stiffness (kPa); US elastography was performed to measure point shear wave speed (SWS) in both liver lobes. We compared: (1) MRE liver and spleen stiffness between controls vs. ARPKD; and (2) MRE liver stiffness between participants with ARPKD without vs. with pHTN, and examined correlations between MRE liver stiffness, spleen length, platelet counts, and US elastography SWS. Receiver operating characteristic (ROC) analysis was performed to examine diagnostic accuracy of liver MRE. RESULTS: Participants with ARPKD (median age 16.8 [IQR 13.3, 18.9] years) had higher median MRE liver stiffness than controls (median age 14.7 [IQR 9.7, 16.7 years) (2.55 vs. 1.92 kPa, p = 0.008), but MRE spleen stiffness did not differ. ARPKD participants with pHTN had higher median MRE liver stiffness than those without (3.60 kPa vs 2.49 kPa, p = 0.05). Liver MRE and US elastography measurements were strongly correlated. To distinguish ARPKD vs. control groups, liver MRE had 78% sensitivity and 93% specificity at a proposed cut-off of 2.48 kPa [ROC area 0.83 (95% CI 0.63-1.00)]. CONCLUSION: Liver MRE may be a useful quantitative method to measure the severity of CHF and pHTN in individuals with ARPKD.
OBJECTIVES: To evaluate whether liver and spleen magnetic resonance elastography (MRE) can measure the severity of congenital hepatic fibrosis (CHF) and portal hypertension (pHTN) in individuals with autosomal recessive polycystic kidney disease (ARPKD), and to examine correlations between liver MRE and ultrasound (US) elastography. METHODS: Cross-sectional study of nine individuals with ARPKD and 14 healthy controls. MRE was performed to measure mean liver and spleen stiffness (kPa); US elastography was performed to measure point shear wave speed (SWS) in both liver lobes. We compared: (1) MRE liver and spleen stiffness between controls vs. ARPKD; and (2) MRE liver stiffness between participants with ARPKD without vs. with pHTN, and examined correlations between MRE liver stiffness, spleen length, platelet counts, and US elastography SWS. Receiver operating characteristic (ROC) analysis was performed to examine diagnostic accuracy of liver MRE. RESULTS: Participants with ARPKD (median age 16.8 [IQR 13.3, 18.9] years) had higher median MRE liver stiffness than controls (median age 14.7 [IQR 9.7, 16.7 years) (2.55 vs. 1.92 kPa, p = 0.008), but MRE spleen stiffness did not differ. ARPKD participants with pHTN had higher median MRE liver stiffness than those without (3.60 kPa vs 2.49 kPa, p = 0.05). Liver MRE and US elastography measurements were strongly correlated. To distinguish ARPKD vs. control groups, liver MRE had 78% sensitivity and 93% specificity at a proposed cut-off of 2.48 kPa [ROC area 0.83 (95% CI 0.63-1.00)]. CONCLUSION: Liver MRE may be a useful quantitative method to measure the severity of CHF and pHTN in individuals with ARPKD.
Authors: Meral Gunay-Aygun; Esperanza Font-Montgomery; Linda Lukose; Maya Tuchman Gerstein; Katie Piwnica-Worms; Peter Choyke; Kailash T Daryanani; Baris Turkbey; Roxanne Fischer; Isa Bernardini; Murat Sincan; Xiongce Zhao; Netanya G Sandler; Annelys Roque; Daniel C Douek; Jennifer Graf; Marjan Huizing; Joy C Bryant; Parvathi Mohan; William A Gahl; Theo Heller Journal: Gastroenterology Date: 2012-10-03 Impact factor: 22.682
Authors: Xiaofang Wang; Megan M Constans; Fouad T Chebib; Vicente E Torres; Lorenzo Pellegrini Journal: Am J Nephrol Date: 2019-05-22 Impact factor: 3.754
Authors: Juan S Calle-Toro; Suraj D Serai; Erum A Hartung; David J Goldberg; Bradley D Bolster; Kassa Darge; Sudha A Anupindi Journal: Abdom Radiol (NY) Date: 2019-03
Authors: Lisa M Guay-Woodford; John J Bissler; Michael C Braun; Detlef Bockenhauer; Melissa A Cadnapaphornchai; Katherine M Dell; Larissa Kerecuk; Max C Liebau; Maria H Alonso-Peclet; Benjamin Shneider; Sukru Emre; Theo Heller; Binita M Kamath; Karen F Murray; Kenneth Moise; Eric E Eichenwald; Jacquelyn Evans; Roberta L Keller; Louise Wilkins-Haug; Carsten Bergmann; Meral Gunay-Aygun; Stephen R Hooper; Kristina K Hardy; Erum A Hartung; Randi Streisand; Ronald Perrone; Marva Moxey-Mims Journal: J Pediatr Date: 2014-07-09 Impact factor: 4.406
Authors: Marzanna Obrzut; Vitaliy Atamaniuk; Bogdan Obrzut; Richard Ehman; Marian Cholewa; Mateusz Rzucidło; Andrii Pozaruk; Krzysztof Gutkowski Journal: Pol Arch Intern Med Date: 2019-02-22